GTHKF yields 1000000.00% · JNJ yields 2.13%● Live data
📍 GTHKF pulled ahead of the other in Year 1
Combined, GTHKF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GTHKF + JNJ for your $10,000?
Genting Hong Kong Limited, an investment holding company, engages in the operation of passenger cruise ships in the Asia Pacific, the United States, Europe, and internationally. It operates through three segments: Cruise and Cruise-Related Activities, Shipyard, and Non-Cruise Activities. The company primarily operates cruise ships under the Star Cruises, Dream Cruises, and Crystal Cruises brands; and MV Werften and Lloyd Werft shipyards, as well as docking facilities. It also operates Resorts World Manila, an integrated resort in the Philippines. In addition, the company is involved in the bareboat chartering business; operation and management of hotels; development of hospitality facilities; development and sale of commercial properties; lease of properties; provision of property management, catering, and management services; and operation of entertainment business. Further, it provides cruise sales, marketing, and support services; newbuilding, conversion, and maintenance services for ships; travel agency services; and owns vessels under construction. The company was formerly known as Star Cruises Limited and changed its name to Genting Hong Kong Limited in 2010. Genting Hong Kong Limited was incorporated in 1993 and is headquartered in Tsim Sha Tsui, Hong Kong.
Full GTHKF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.